Clinical Trial Update: Modafinil as an Adjunctive on Cognitive Functioning in Patients With Schizophrenia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update evaluating modafinil as an adjunct to standard treatment to improve cognitive functioning in patients with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Modafinil (modafinil)

Snippet

Sponsor: Laval University | Conditions: Schizophrenia and Schizophrenia Spectrum Psychosis | Phase 1, Phase 2 | Status: COMPLETED